Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

First university-based research center devoted to studying epigenetics

With a $5 million, five-year federal grant, The Johns Hopkins University School of Medicine is establishing what is believed to be the first university-based research center devoted to studying epigenetics

28 Jun 2004

Common illnesses are associated with an increased risk of suicide in elderly people

Many common illnesses are independently associated with an increased risk of suicide in elderly people, according to an article in the June 14 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.

15 Jun 2004

Antipsychotic compound bifeprunox worth USD 1 billion per year to Solvay and Wyeth

Solvay has re-evaluated the commercial potential of bifeprunox, a Solvay compound in clinical development for the treatment of schizophrenia . Bifeprunox additionally has the potential to be developed in other disorders, i.e. bipolar disorder.

3 Jun 2004

Bipolar disorder, one of the illnesses that will be studied and treated at the new Mood Disorders Centre of Excellence

Imagine suffering frequent, extreme and disabling mood swings that won’t go away despite years of different treatments and diagnoses.

26 May 2004

Public Health Advisory for medical professionals with patients on anti-depression medication

On Monday, March 22, 2004 the Food and Drug Administration issued a Public Health Advisory for medical professionals to monitor for signs of suicidal ideation in individuals who have recently started taking anti-depression medication or have had a recent change in dosage, especially for children who are taking these medications. Antidepressant medications involved in this warning include: Prozac (Fluoxetine), Zoloft, Paxil, Luvox, Celexa, Lexapro, Wellbutrin, Effexor,, Serzone, and Remeron.

25 Apr 2004

New Data Show Behavioral Education Program Helps Patients Treated with Antipsychotic Medications Reduce Weight and Improve Overall Wellness

Patients with severe and persistent mental illness treated with antipsychotic medications reported positive changes in diet, exercise, stress management, improved sleep, and increased confidence in maintaining these lifestyle changes after participating in the Solutions for Wellness Personalized Program (SFWPP), new data show.

22 Apr 2004

FDA has approved Zyprexa, injectable anti-psychotic drug

Physicians have a new fast-acting option for controlling the potentially crippling effects of acute agitation in patients suffering with schizophrenia and bipolar mania. The U.S. Food and Drug Administration (FDA) has approved Zyprexa® IntraMuscular (olanzapine for injection), an injectable form of Lilly's top-selling medication.

30 Mar 2004

Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

First university-based research center devoted to studying epigenetics

Common illnesses are associated with an increased risk of suicide in elderly people

Antipsychotic compound bifeprunox worth USD 1 billion per year to Solvay and Wyeth

Bipolar disorder, one of the illnesses that will be studied and treated at the new Mood Disorders Centre of Excellence

Public Health Advisory for medical professionals with patients on anti-depression medication

New Data Show Behavioral Education Program Helps Patients Treated with Antipsychotic Medications Reduce Weight and Improve Overall Wellness

FDA has approved Zyprexa, injectable anti-psychotic drug

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

First university-based research center devoted to studying epigenetics

Common illnesses are associated with an increased risk of suicide in elderly people

Antipsychotic compound bifeprunox worth USD 1 billion per year to Solvay and Wyeth

Bipolar disorder, one of the illnesses that will be studied and treated at the new Mood Disorders Centre of Excellence

Public Health Advisory for medical professionals with patients on anti-depression medication

New Data Show Behavioral Education Program Helps Patients Treated with Antipsychotic Medications Reduce Weight and Improve Overall Wellness

FDA has approved Zyprexa, injectable anti-psychotic drug

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in